SEC Form 4 · accession 0001603963-17-000003
BIO-PATH HOLDINGS INC · BPTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark P Colonnese
Director
Period of report
Jul 13, 2017
Accepted (ET)
Jul 17, 2017 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133818
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Option (right to buy)F1 | $0.38 | Jul 13, 2017 | A | 25,000 | A | — | Jul 13, 2027 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of July 13, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc.